Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ARCH.Vthis companyArch Biopartners Inc.	CA$0.89	-54.01×	-21.63×	0×	-67.06×	-107.1%	0.0%	0.0%	0.0%	40.0%	145.7%	-1.9%	-0.73×	-2.19×	-5.88×	0.03×	0.0%	2	-1,107.49	2	C
DTC.CNDefence Therapeutics Inc.	CA$0.36	-4×	7.79×	0×	-5.53×	-98.2%	0.0%	0.0%	0.0%	-190.7%	-94.2%	-17.4%	0.49×	0.03×	-12.15×	3.42×	0.0%	2	-5.63	1	C-
Peer median	—	-4×	7.79×	0×	-5.53×	-98.2%	0.0%	0.0%	0.0%	-190.7%	-94.2%	-17.4%	0.49×	0.03×	-12.15×	3.42×	0.0%	2	-5.63	1	—